Boehringer collaborates with Havard
July 9, 2012Research and Development, Sales and Marketing Boehringer, Havard, oncology, research deal
Boehringer Ingelheim has established a translational research collaboration with the presidents and fellows of Harvard College. The aim of the …
The problem with medical publishing
July 6, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, MMR, medical publishing
I’ve often said that however bad one’s research, it’s possible to get it published somewhere. I have been thinking about …
More job cuts planned at Sanofi, says union
July 6, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Viehbacher, cuts
Sanofi has confirmed that it is considering a restructuring of its operations in France, but has refused to comment on …
Erbitux fails in gastric cancer trial
July 6, 2012Research and Development, Sales and Marketing Erbitux, Merck Serono, Roche, failure, gastric cancer
Merck’s Erbitux has failed to increase survival in patients with gastric cancer, representing a blow to the firm’s ambition to …
GolinHarris to acquire Virgo HEALTH
July 6, 2012Medical Communications, Sales and Marketing GolinHarris, Med Comms, Virgo HEALTH, acquisition, agency, digital
GolinHarris, a division within Interpublic Group, will acquire the medical communications firm Virgo HEALTH. Virgo HEALTH will retain its name …
NICE no for Avastin in breast cancer
July 6, 2012Sales and Marketing NICE, Roche, avastin, breast cancer, rejection
NICE has decided once again not to recommend Roche’s Avastin on the NHS for the first line treatment of metastatic …
Watermeadow acquired by United Drug
July 5, 2012Medical Communications United Drug, Watermeadow
Medical communications agency Watermeadow has been acquired by healthcare conglomerate United Drug for €16.25m. The acquisition means Watermeadow joins a …
New malaria drug ready for launch
July 5, 2012Sales and Marketing ACT, Sigma Tau, Sigma-Tau, malaria
Eurartesim, the first artemisinin combination therapy (ACT) approved in Europe to treat uncomplicated malaria, is being prepared for launch in …
Boehringer Ingelheim makes changes to board
July 5, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim
Boehringer Ingelheim has appointed Dr Joachim Hasenmaier to its board of managing directors. The 52-year-old will take over responsibility for …
New chairman of the board for Dendreon
July 5, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Dendreon, Provenge, johnson, prostate cancer
Dendreon has announced that its president and chief executive John Johnson has assumed the additional title of chairman of the …
NHS Board’s draft ‘mandate’ unveiled
July 5, 2012Sales and Marketing CCGs, NHS, NHS Commissioning Board
Health Secretary Andrew Lansley has unveiled the proposed ‘mandate’ for the NHS Commissioning Board, the set of strategic goals the …
BioCity Scotland appoints new managing director
July 5, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing BioCity Scotland, Fraser Black, GE Life Sciences
Former Global Services Solutions director with GE Life Sciences, Fraser Black, has been appointed as managing director of BioCity Scotland, …
GSK ruling: Another failing, but will the industry learn?
July 4, 2012Medical Communications, Sales and Marketing GSK, fraud, legal, marketing fine
Court papers surrounding GSK’s $3 billion fraud charge make for grim reading, and further damages an industry that already struggles …
New head at the European Medicines Agency
July 4, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, Merck Serono, Stallergenes
Merck Serono’s Enrica Alteri has been appointed by The European Medicines Agency as its new head of Safety and Efficacy …
Janssen submits tuberculosis pill to FDA
July 4, 2012Research and Development, Sales and Marketing Bedaquiline, FDA, J&J, JJ, Janssen, tuberculosis
Janssen has submitted its investigational tuberculosis pill bedaquiline for review by the FDA. The firm is seeking a licence for …
New chair of the English Pharmacy Board
July 4, 2012Business Services, Research and Development, Sales and Marketing English Pharmacy Board, Shilpa Gohil
Shilpa Gohil has been elected chair of the English Pharmacy Board at the first meeting of the newly elected board, …
Nova Laboratories to supply leukaemia drug across Europe
July 4, 2012Manufacturing and Production
‘Xaluprine’, a liquid form of childhood leukaemia drug Mercaptopurine, will be distributed to hospital pharmacies across Europe after being granted …
Sluggish growth forecast concerns ABPI
July 3, 2012Sales and Marketing ABPI, NHS, OHE, VBP, government
New forecasts suggest that spending on branded drugs may fall in real terms by 2015, leading the ABPI to call …
Wellcome Trust appoints UK chief scientific adviser
July 3, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing UK government, Wellcome Trust
The director of the Wellcome Trust since 2003 Sir Mark Walport has been appointed to succeed Sir John Beddington as …
MPs warn of dementia delays
July 3, 2012Research and Development, Sales and Marketing APPG, Alzheimer's, dementia, government
Patients with dementia are facing huge delays in their diagnosis and treatment according to a group of MPs and peers. …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
